{
  "id": 16431,
  "url": "https://medcitynews.com/2026/08/pathos-ai-agent-agentic-cancer-alphamab-trop2-her3-bispecific-adc-astrazeneca-azn",
  "title": "Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents",
  "summary": "Pathos AI struck a deal for rights to a bispecific antibody drug conjugate from Alphamab that could become first in a new class of cancer drugs. Separately, the startup began a partnership with AstraZeneca on a protein degrader from the pharma company’s cancer drug pipeline. The post Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents appeared first on MedCity News .",
  "authors": "Frank Vinluan",
  "category": "news",
  "topics": "healthcare,agents-autonomy,biotech",
  "orgs": null,
  "regions": null,
  "published_at": "2026-08-04T20:17:52.000Z",
  "fetched_at": "2026-08-05T05:10:44.550Z",
  "source_slug": "x-medcity-news-ai",
  "source_name": "MedCity News AI",
  "source_homepage": "https://medcitynews.com/tag/artificial-intelligence/",
  "ethics_ai_record_url": "https://ethics.ai/record/16431",
  "original_url": "https://medcitynews.com/2026/08/pathos-ai-agent-agentic-cancer-alphamab-trop2-her3-bispecific-adc-astrazeneca-azn",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}